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Although the beneﬁts of regular exercise in controlling cardiovascular risk factors have been extensively proven, little is known about the
long-term cardiovascular effects of regular and extreme endurance sport practice, such as jogging, cycling, rowing, swimming, etc. Recent data
from a small series suggest a relationship between regular, long-term endurance sport practice and atrial ﬁbrillation (AF) and ﬂutter.
Reported case control studies included less than 300 athletes, with mean age between 40 and 50. Most series recruited only male patients,
or more than 70% males, who had been involved in intense training for many years. Endurance sport practice increases between 2 and 10
times the probability of suffering AF, after adjusting for other risk factors. The possible mechanisms explaining the association remain specu-
lative. Atrial ectopic beats, inﬂammatory changes, and atrial size have been suggested. Some of the published studies found that atrial size was
larger in athletes than in controls, and this was a predictor for AF. It has also been shown that the left atrium may be enlarged in as many as
20% of competitive athletes. Other proposed mechanisms are increased vagal tone and bradycardia, affecting the atrial refractory period;
however, this may facilitate rather than cause the arrhythmia. In summary, recent data suggest an association between endurance sport
practice and atrial ﬁbrillation and ﬂutter. The underlying mechanism explaining this association is unclear, although structural atrial
changes (dilatation and ﬁbrosis) are probably present. Larger longitudinal studies and mechanistic studies are needed to further characterize
the association to clarify whether a threshold limit for the intensity and duration of physical activity may prevent AF, without limiting the
cardiovascular beneﬁts of exercise.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Regular and extreme endurance sport practice (jogging, cycling,
swimming, etc.) has become very popular even among adults in
their forties. The beneﬁts of regular exercise in controlling
cardiovascular risk factors have been extensively proved,
1–4
and therefore cardiologists widely recommend regular exercise
to improve cardiovascular health. However, recent data have
documented a relationship between long-term endurance
sport practice or rigorous occupational physical activity and
atrial ﬁbrillation (AF) and atrial ﬂutter.
5–10 The association is
being increasingly recognized and has raised the need for
larger epidemiological studies.
11–13 On the other hand, moder-
ate physical activity may indeed decrease the risk for AF in
older adults.
14
Atrial ﬁbrillation is the most common arrhythmia and has a great
impact in morbidity and mortality.
15,16 The current increase in
incidence is not fully explained by the aging population or higher
prevalence of newly described risk factors such as obesity.
17,18
Therefore, non-identiﬁed factors apart from family history
19 may
be present. Atrial ﬁbrillation is associated with a number of
cardiac and extracardiac diseases, such as hypertension, structural
heart disease, and hyperthyroidism. However, in a signiﬁcant pro-
portion of patients, its aetiology remains unknown.
20 This condition,
called lone AF (LAF), is deﬁned as AF in patients younger than age
60 and without any identiﬁable aetiologic factor. The prevalence
of LAF ranges from 2–10% in the general population to 30% in
studies performed in patients with paroxysmal AF who seek
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21,22 Lone atrial ﬁbrillation is commonly associated
with atrial ﬂutter, as described by Coumel;
23 therefore, they seem to
be two expressions of the same underlying condition.
The aim of this review is to analyse the evidence of the
association between LAF and endurance sport practice or
occupational physical activity, the pathophysiological mechanisms
underlying this association, the clinical characteristics of this
arrhythmia, and the available therapeutic options.
Atrial ﬁbrillation and endurance
sport practice
Although the presence of AF in athletes had been described pre-
viously,
24,25 to the best of our knowledge Karjalainen et al.
5 were
the ﬁrst, in 1998, to publish a longitudinal prospective study estab-
lishing a relationship between endurance sport practice and AF.
They studied a series of orienteers (an endurance sport often prac-
ticed in Scandinavia). After 10 years of follow-up, AF incidence
among orienteers was 5.3%, when compared with 0.9% among
the control subjects. Therefore, the incidence of AF was unusually
high in a series of middle-aged endurance sport practitioners
without predisposing factors. Furthermore, the two patients with
AF in the control group were also involved in endurance practice.
The odds ratio for LAF associated with vigorous exercise was 5.5
(95% conﬁdence interval: 1.3–24.4) in this study (Table 1).
Our interest in the subject also began in 1998. A retrospective
analysis of our series of LAF patients seen at the outpatient
arrhythmia clinic showed that the proportion of regular sport
practice among men with LAF was much higher than among men
from the general population (63 vs. 15%).
6 In that series, a rather
lax deﬁnition of sport practice was used (more than 3 h a week at
the moment of evaluation), but in fact most patients had been
involved in endurance sport practice for more than 10 years, with
much higher participation levels in the past. Some of them had
already limited their practice as a consequence of the arrhythmia.
The same population of LAF patients was analysed in a case–
control study with two age-matched controls for each case from
the general population.
7 The analysis showed that the current
sport practice increased the risk of developing LAF more than
ﬁve times (OR 5.06 (1.35–19), a result that is within the range
reported by Karjalainen et al.
5 It is noteworthy that the association
of current sport practice with LAF was observed at more than
1500 lifetime hours of sport practice, suggesting the existence of
a threshold point. Of course, this threshold point should be inter-
preted with caution, and probably points out the pattern of the
association (i.e. number of hours of sport practice and a posterior
plateau) rather than the exact threshold point (Table 1).
To conﬁrm the association between endurance sports and AF in
a longitudinal manner, our group undertook a study that included
183 individuals who ran the Barcelona Marathon in 1992 and 290
sedentary healthy individuals included in the REGICOR study.
9,26
After 10 years of follow-up, the annual incidence rate of LAF
among marathon runners and sedentary men was 0.43/100 and
0.11/100, respectively. Endurance sport practice was associated
with a higher risk of incident LAF in the multivariable age- and
blood pressure-adjusted Cox regression models (hazard ratio ¼
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L. Mont et al. 128.80; 95% conﬁdence interval: 1.26–61.29). The main limitation of
this study was the small number of events observed during
follow-up (n ¼ 9 among marathon runners and n ¼ 2 among
sedentary men). Nevertheless, the results were consistent with
previous observations.
5,7
Recently, Baldesberger et al.
27 published similar data in a study of
64 former Swiss professional cyclists who completed the Tour de
Suisse professional cycling race at least once during the years
1955–1975. These athletes were compared with a control group
of 62 male golfers who had never performed high-endurance train-
ing. Individuals were matched for age, weight, hypertension, and
cardiac medication. The mean age at examination was 66+7
years. Former cyclists showed a lower heart rate and a higher inci-
dence of AF or atrial ﬂutter (10 vs. 0%, P , 0.028) and non-
sustained ventricular tachycardia (VT). The higher proportion of
AF and ﬂutter when compared with the study by Kaarjalainen
et al.
5 or by Molina et al.
9 is probably explained because this study
population was older. These data suggest that incidence of AF and
ﬂutter further increases with aging in athletes, as with any kind of AF.
In contrast with these previous studies, Pellicia et al.
28 reported
that the incidence of LAF among competitive athletes was uncom-
mon and similar to that observed in the general population.
However, the study was performed in young athletes at the
moment of highest activity. Studies supporting the association
have been performed in middle-aged individuals, after many
years of sport practice.
Atrial ﬂutter and endurance sport
practice
Most of the described series include patients suffering concomitant
AF and atrial ﬂutter, suggesting that endurance sports contri-
bute to the development of both arrhythmias. For example,
Baldesberger et al.
27 found a higher incidence of ﬂutter than AF
in their series of veteran cyclists, although the authors did not
describe whether these were common or atypical ﬂutter episodes.
Heidbuchel et al.
8 found that endurance athletes had a higher
recurrence rate for AF than did controls (Figure 1). The authors
conclude that endurance sport practice increases the risk of
suffering AF after common ﬂutter ablation. Hoogsteen et al.
29
found that 10% of athletes with AF also suffer episodes of atrial
ﬂutter. These observations suggest that both arrhythmias often
co-exist in endurance athletes, and common ﬂutter may be second-
ary to right atrial dilatation as a consequence of volume overload.
Atrial ﬁbrillation and occupational
physical activity
These studies seem to have established that long-lasting endurance
sport practice increases the risk of LAF. Vigorous physical activity
associated with occupational activities may theoretically pose a
similar risk. Data from the recently published GIRAFA study
10
appear to conﬁrm this theory. The prospective GIRAFA study
is conducted in consecutive patients with LAF recruited at the
emergency room. In this case–control study, 107 LAF patients
were compared with age- and sex-matched healthy controls.
Total hours of physical activity (during work or leisure time)
were collected with a detailed and validated questionnaire. For
each physical activity, the following variables were recorded:
age started, age ended, months per year, days per week, and
hours per day. Subjects were asked to classify the intensity of
each physical activity in four levels: sedentary, light, moderate,
and heavy. The results showed that the moderate and heavy phys-
ical activity, whether sport- or job-related, increased the risk of
suffering AF. In multivariable analysis, physical activity and atrial
size were independent predictors for the development of AF,
even after normalizing by body surface area (BSA) and height. In
contrast with these observations, The Danish Diet Cancer and
Health Study, conducted in a population of 19 593 men and
18 807 women with a mean age of 56 (range 50–65), failed to
demonstrate any association between physical activities during
working hours and risk of hospitalization with a diagnosis of AF
or ﬂutter.
30 This discrepancy may be due to the limited categoriz-
ation and quantiﬁcation of physical activity, compared to the much
deeper analysis in the GIRAFA study. Further epidemiological
studies, with a detailed quantiﬁcation of work-associated physical
activity, are needed to clarify this potential association.
It is interesting to note the GIRAFA study’s association of height
and atrial size (absolute and normalized) with AF. In understanding
the male predominance observed in AF, sex may indeed be secon-
dary to that association. Hanna et al.
31 had already reported a
relationship between stature and AF prevalence in patients with
left ventricular (LV) dysfunction (Figure 2).
Pathophysiology of sport-related
atrial ﬁbrillation
What is the possible link between physical activity and AF? Several
mechanisms may be acting together. It is well accepted that
arrhythmias depend on triggers, substrates, and modulators, and
Figure 1 Patients with a history of endurance sports before
ablation (n ¼ 31) developed signiﬁcantly more atrial ﬁbrillation
than controls or those with a history of other type o sports
activity after ﬂutter ablation (reproduced from reference 8,
with permission).
Endurance sport practice as a risk factor 13these factors may be present in relation to physical activity
(Figure 3).
Triggers: role of atrial ectopy
Atrial ectopy, particularly pulmonary vein ectopy, has been shown
to be the trigger in most episodes of paroxysmal AF.
32 Atrial and
ventricular ectopy may be increased as a consequence of physical
activity.
27,33 Moreover, increased ventricular ectopy in elite athletes
is reversible after detraining.
34 Therefore, increased ectopy may be
one of the mechanisms explaining the increased risk for AF associ-
ated with sport practice, provided that this ectopy acts upon an
appropriate substrate. However, a recent paper by Baldesberger
et al.
27 did not ﬁnd an increased incidence of atrial ectopy, despite
increases in ventricular ectopy and VT runs in former professional
cyclists. Therefore, the hypothesis of increased atrial ectopy as an
explanation for the association between sports and AF cannot be
adequately sustained with currently available data.
Modulators: inﬂuence of autonomic
nervous system
Why does an apparently healthy individual start suffering from AF?
Coumel
35 studied the inﬂuence of autonomic innervations in the
appearance of AF and atrial ﬂutter. He reported: ‘Vagally mediated
AF occurs more frequently in men than in women, with a ratio of
4:1’. The age at which the ﬁrst symptoms appear is classically
between40and50years[sic].Theessentialfeatureistheoccurrence
ofthe AFat night, often ending inthe morning. Rest,the postprandial
state (particularly after dinner) and alcohol are also precipitating
factors [sic]
36 (Figure 4). The author concluded that although AF
occurred in a vagal context, an unidentiﬁed substrate probably
existed. However, he did not establish a relationship between
these episodes of AF and sport practice.
Experimental data show that increased vagal tone shortens
and increases the dispersion of the atrial refractory period, creating
the conditions for re-entry.
37–39 However, vagal AF is considered
to be a rare presentation of AF. This is probably due to the lack of
systematic inquiry with patients. According to the GIRAFA study,
10
vagal AF is the rule rather than the exception in LAF patients
(70% of consecutive LAF patients had vagal AF). Therefore,
the increased vagal tone induced by endurance sport practice
may indeed facilitate the appearance of AF. In fact, heart rate
Figure 3 Classical triangle of Coumel suggesting possible etio-
pathogenic factors inﬂuencing the development of atrial ﬁbrilla-
tion in athletes.
Figure 4 Twenty-four hours recording of heart rate showing a
nocturnal episode of atrial ﬁbrillation.
Figure 2 Thin-plate smoothing spline regression results assessing the non-linear relation between height and occurrence of lone atrial ﬁbrilla-
tion (left panel), and the linear relation between left atrial (LA) diameter and occurrence of lone atrial ﬁbrillation (right panel) (reproduced from
reference 9, with permission).
L. Mont et al. 14is still lower in former athletes many years after cessation of
professional training than in controls, as recently shown by
Baldesberger et al.
27
Another interesting hypothesis recently raised by Swanson
40 in a
review of the existing literature is that gastroesophageal reﬂux,
which indeed has been proven to produce AF and vagal reﬂexes,
may be the link between increased AF and exercise. However,
this hypothesis has not yet been properly investigated.
Arrhythmia substrate
Whether there is a structural substrate in LAF is still a matter of
debate. In patients with hypertension or structural heart disease,
it seems that AF is the consequence of structural changes in the
atria (dilatation and ﬁbrosis) secondary to chronic volume and
pressure overload. It is therefore plausible that long-term endur-
ance sport practice or occupational physical activity may induce
structural changes in the atrium (enlargement, ﬁbrosis) that may
create a favourable substrate for the disease. In fact, Frustaci
et al.
41 found structural changes in a series of 12 patients with par-
oxysmal, recurrent, drug refractory LAF. The authors described
inﬂammatory lymphonomonuclear inﬁltrates, compatible with
myocarditis, in 66% of patients; a non-inﬂammatory cardiomyo-
pathic process in 17%; and patchy ﬁbrosis in the remaining 17%.
Whether the data correspond to a highly selected population
cannot be deﬁnitively ruled out, but 100% of patients showed his-
tological changes. On the other hand, these changes could have
been produced by repetitive episodes of AF.
A recent review of the literature by Swanson
42 shows that
excessive endurance exercise and overtraining can lead to
chronic systemic inﬂammation and there is a relationship
between AF and C-reactive protein. Anti-inﬂammatory agents
have been reported to lower C-reactive protein and ameliorate
AF. Whether inﬂammation may be mediated by the renin–
angiotensin system and a sustained increase in catecholamines
remains to be elucidated. At present, no published studies
combine these three concepts: AF, inﬂammation, and exercise.
Additional studies are needed.
Although the underlying mechanism for structural changes is
not clear, recent echocardiographic data suggest that structural
remodelling is often present in the atrium of elite athletes
without AF. Pelliccia et al.
28 recently published a study that
describes the remodelling induced by exercise in elite sport
athletes. Their data showed that those involved in regular
endurance practice have a larger atrium when compared
with sedentary controls. Furthermore, a signiﬁcant proportion
(20%) showed enlarged atria according to established normal
values.
GIRAFA study data
10 showing that patients with LAF had a
larger atrium when compared with controls suggest that subtle
structural changes at the atrial level may account for the appear-
ance of AF. The study further showed that patients with a ﬁrst
episode of AF had the same atrial size when compared with
those suffering recurrences. Therefore, it seems that structural
changes were present before onset of AF. On the other hand,
patients with AF had larger LV mass, even after normalizing
for BSA. This further supports the idea that exercise also had
some repercussions in the ventricles, but without differences in
diastolic function index when compared with controls. Although
diastolic dysfunction has been proposed as the mechanistic
background for atrial enlargement, it seems that volume and
pressure overload act directly in the atrium, even before acting
at the ventricular level.
A recent case–control study by Lindsay and Dunn
43 involving 45
veteran athletes showed biochemical evidence of a disruption of
the collagen equilibrium that would favour ﬁbrosis. Athletes
showed an increase in three collagen markers, plasma PICP,
CITP, and TIMP-1, when compared with sedentary controls. The
authors suggest that ﬁbrosis occurs as part of the hypertrophic
process in veteran athletes. Furthermore, an increase in ﬁbrosis
at the atrial and right ventricular level has been shown in a
model of endurance exercise in rats.
44
Another factor that has been suggested as a cause of AF is
the use of anabolic steroids. Although some isolated case
reports show a link between AF and steroids,
45,46 the cases have
presented in young athletes, at the moment of maximal physical
activity, whereas AF in endurance sports seems to occur in
middle-aged men, years after cessation of professional competitive
or maximal activity. Therefore, although anabolic steroids may
have a role in the genesis of AF, it is probably marginal. If atrial
enlargement and ﬁbrotic changes precede AF, what is the role
of vagal tone and pulmonary veins in premature beats? It
could be that in AF secondary to physical activity, vagal tone and
ectopics may act more as a trigger and modulator than as the
cause itself.
Clinical characteristics of
sport-related atrial ﬁbrillation
The typical clinical proﬁle of sport-related AF or atrial ﬂutter is a
middle-aged man (in his forties or ﬁfties) who has been involved
in regular endurance sport practice since his youth (soccer,
cycling, jogging, and swimming), and is still active. This physical
activity is his favourite leisure time activity and he is psychologically
very dependent on it. The AF is usually paroxysmal with crisis,
initially very occasional and self limited, and progressively increas-
ing in duration. Characteristically, AF episodes occur at night or
after meals. As many as 70% of patients may suffer predominantly
vagal AF.
10 They almost never occur during exercise. This makes
the patient reluctant to accept a relationship between the arrhyth-
mia and sport practice, particularly since his physical condition is
usually very good. The crises typically become more frequent
and prolonged over the years and AF becomes persistent. Pro-
gression to permanent AF has been described by Hoogsteen
et al. in 17% of individuals in an observational series. In the
GIRAFA study, 43% presented persistent AF.
10,29 The AF crisis fre-
quently coexists with common atrial ﬂutter in many patients, as
previously discussed.
Therapeutic measures
Although data on the reversibility of arrhythmia upon sport cessa-
tion are scarce, Furlanello et al.
25 have described a good response
to sport abstinence in top-level athletes with AF. Our
Endurance sport practice as a risk factor 15observations, although not systematic, suggest that limiting physical
activity seems to signiﬁcantly reduce the number of crises, particu-
larly in those with recent onset and minimally dilated atrium.
However, these patients are very dependent on physical activity
and it is difﬁcult for them to follow this advice. Previous studies
have demonstrated the reversibility of hypertrophic changes at
the ventricular level in the hearts of athletes. Bifﬁ et al.
34 also
showed a very signiﬁcant decrease in ventricular ectopy upon
sport cessation. Therefore, while awaiting more deﬁnitive data, it
seems advisable to signiﬁcantly reduce endurance sport practice
in these cases.
The possible long-term role of drugs (ACE inhibitors, angioten-
sin inhibitors, or beta-blockers) in preventing cardiac hypertrophy
remains to be elucidated, although angiotensin blockers do seem
to play a role in improving the results of cardioversion or AF abla-
tion.
47,48 In terms of arrhythmia prevention, patients with recur-
rent episodes have been treated with ﬂecainide and diltiazem,
preventing 1:1 atrial ﬂutter secondary to ﬂecainide with good
results. Some of them had undergone AF ablation with a success
rate similar to patients not involved in endurance sport practice
(authors’ unplublished observations). In patients with predominant
atrial ﬂutter, ablation of the ﬂutter is frequently associated with a
higher incidence of AF recurrences, as pointed out by Heidbuchel
et al.
8 A recent study by Furlanello et al.
49 described a highly suc-
cessful ablation, with 90% success after a mean of two ablation
procedures in a series of 20 athletes, without major complications.
Apparently, the goal of the ablation was to allow rather veteran
athletes (44+13 years) to re-initiate their competitive activity.
The reported series may represent a selected series of patients,
since most of them presented exercise-induced AF, in contrast
with the reported prevalence of vagal AF among endurance
athletes. Although ablation seems to be quite effective, endurance
sport cessation associated with drug therapy seems to us a more
suitable approach as an initial therapy, particularly in non-
professional, veteran athletes.
Conclusions
Vigorous physical activity, whether related to long-term endurance
sport practice or to occupational activities, seems to increase
the risk for recurrent AF. The underlying mechanisms remain to
be elucidated, although structural atrial changes (dilatation and
ﬁbrosis) are probably present. There is a relationship between
accumulated hours of practice and AF risk. Further studies are
needed to clarify whether a threshold limit for the intensity and
duration of physical activity may prevent AF, without limiting the
cardiovascular beneﬁts of exercise.
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